These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26598221)

  • 1. Drug delivery to bony tissue.
    Balmayor ER; van Griensven M
    Adv Drug Deliv Rev; 2015 Nov; 94():1-2. PubMed ID: 26598221
    [No Abstract]   [Full Text] [Related]  

  • 2. The application of nanomaterials in controlled drug delivery for bone regeneration.
    Shi S; Jiang W; Zhao T; Aifantis KE; Wang H; Lin L; Fan Y; Feng Q; Cui FZ; Li X
    J Biomed Mater Res A; 2015 Dec; 103(12):3978-92. PubMed ID: 26061384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffolds for vascularized bone regeneration: advances and challenges.
    Boccaccini AR; Kneser U; Arkudas A
    Expert Rev Med Devices; 2012 Sep; 9(5):457-60. PubMed ID: 23116071
    [No Abstract]   [Full Text] [Related]  

  • 4. A biomimetic growth factor delivery strategy for enhanced regeneration of iliac crest defects.
    Huri PY; Huri G; Yasar U; Ucar Y; Dikmen N; Hasirci N; Hasirci V
    Biomed Mater; 2013 Aug; 8(4):045009. PubMed ID: 23782488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Material-related effects of BMP-2 delivery systems on bone regeneration.
    Hernández A; Sánchez E; Soriano I; Reyes R; Delgado A; Évora C
    Acta Biomater; 2012 Feb; 8(2):781-91. PubMed ID: 22023753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone regeneration with biomaterials and active molecules delivery.
    D' Este M; Eglin D; Alini M; Kyllonen L
    Curr Pharm Biotechnol; 2015; 16(7):582-605. PubMed ID: 25658379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomaterial characteristics important to skeletal tissue engineering.
    Lim JY; Donahue HJ
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):396-8. PubMed ID: 15758276
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteoinductive biomaterials--properties and relevance in bone repair.
    Habibovic P; de Groot K
    J Tissue Eng Regen Med; 2007; 1(1):25-32. PubMed ID: 18038389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and targeted drug delivery for bone regeneration.
    Newman MR; Benoit DS
    Curr Opin Biotechnol; 2016 Aug; 40():125-132. PubMed ID: 27064433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peculiarities of bone tissue regeneration when using various osteoplastic materials in experiment].
    Trunin DA; Volova LT; Bezzubov AE; Kirillova VP; Belozertseva EA
    Stomatologiia (Mosk); 2008; 87(5):4-8. PubMed ID: 19008818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic drug delivery systems for bone tissue regeneration- a mini review.
    Xinluan W; Yuxiao L; Helena NH; Zhijun Y; Ling Q
    Curr Pharm Des; 2015; 21(12):1575-83. PubMed ID: 25594406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid conjugated poly(lactide-co-glycolide): long-term controlled drug release and tissue regeneration for bone tuberculosis therapy.
    Huang D; Li D; Wang T; Shen H; Zhao P; Liu B; You Y; Ma Y; Yang F; Wu D; Wang S
    Biomaterials; 2015 Jun; 52():417-25. PubMed ID: 25818448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-controlled release system of drugs for bone regeneration.
    Kim YH; Tabata Y
    Adv Drug Deliv Rev; 2015 Nov; 94():28-40. PubMed ID: 26079284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.
    Jayaraman P; Gandhimathi C; Venugopal JR; Becker DL; Ramakrishna S; Srinivasan DK
    Adv Drug Deliv Rev; 2015 Nov; 94():77-95. PubMed ID: 26415888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-operatively customized implant coating strategies for local and controlled drug delivery to bone.
    Trajkovski B; Petersen A; Strube P; Mehta M; Duda GN
    Adv Drug Deliv Rev; 2012 Sep; 64(12):1142-51. PubMed ID: 22664228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of growth factors for bone regeneration.
    Yun YR; Jang JH; Jeon E; Kang W; Lee S; Won JE; Kim HW; Wall I
    Regen Med; 2012 May; 7(3):369-85. PubMed ID: 22594329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium phosphate bone substitutes.
    Ginebra MP; Aparicio C; Engel E; Navarro M; Javier Gil F; Planell JA
    Med J Malaysia; 2004 May; 59 Suppl B():65-6. PubMed ID: 15468821
    [No Abstract]   [Full Text] [Related]  

  • 18. A sustained release of lovastatin from biodegradable, elastomeric polyurethane scaffolds for enhanced bone regeneration.
    Yoshii T; Hafeman AE; Nyman JS; Esparza JM; Shinomiya K; Spengler DM; Mundy GR; Gutierrez GE; Guelcher SA
    Tissue Eng Part A; 2010 Jul; 16(7):2369-79. PubMed ID: 20205517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical mesoporous silica nanofibers as multifunctional scaffolds for bone tissue regeneration.
    Ravichandran R; Gandhi S; Sundaramurthi D; Sethuraman S; Krishnan UM
    J Biomater Sci Polym Ed; 2013; 24(17):1988-2005. PubMed ID: 23862629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue response to hydroxylapatite implant in the femurs of rabbits].
    Choie MK; Bae C
    Taehan Chikkwa Uisa Hyophoe Chi; 1987 Jan; 25(1):71-8. PubMed ID: 3036977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.